Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
Authors
Keywords
MPN, PV, ET, PMF, MPN-U, Thrombosis, Thromboembolism, Major bleeding, Anticoagulation
Journal
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-05
DOI
10.1186/s13045-016-0242-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
- (2014) Stephan Kreher et al. ANNALS OF HEMATOLOGY
- Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
- (2014) Bing Li et al. Journal of Hematology & Oncology
- Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: A physician survey
- (2014) Martin H. Ellis et al. THROMBOSIS RESEARCH
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
- (2013) H. Gisslinger et al. BLOOD
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
- Inzidenz und Überleben bei Leukämien in Deutschland nach aktuellen standardisierten Kategorien
- (2013) A. Nennecke et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2 Mutation-Related Disease and Thrombosis
- (2013) Paola Guglielmelli et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Are MPNs Vascular Diseases?
- (2013) Guido Finazzi et al. Current Hematologic Malignancy Reports
- Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
- (2012) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Dysfunction of the PI3 kinase/Rap1/integrin IIb 3 pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia
- (2012) S. F. Moore et al. BLOOD
- Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
- (2012) P. J. Campbell et al. BLOOD
- Front-line therapy in polycythemia vera and essential thrombocythemia
- (2012) Tiziano Barbui et al. BLOOD REVIEWS
- Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
- (2012) Malin Hultcrantz et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
- (2012) Rocco Piazza et al. NATURE GENETICS
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
- (2012) Giovanni Barosi et al. Current Hematologic Malignancy Reports
- TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms
- (2011) Luz Martínez-Avilés et al. ANNALS OF HEMATOLOGY
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
- (2011) J. HOEKSTRA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
- (2011) H Reikvam et al. LEUKEMIA
- Thrombosis in primary myelofibrosis: incidence and risk factors
- (2009) T. Barbui et al. BLOOD
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- (2008) J.-J. Kiladjian et al. BLOOD
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
- Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
- (2008) F Cervantes et al. LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started